Manufacturing and Production

Showing 15 posts of 5857 posts found.

CMA to review AstraZeneca’s $39 billion buyout of Alexion

May 25, 2021 Manufacturing and Production

The UK’s Competition and Markets Authority (CMA) is to review AstraZeneca’s $39 billion buyout of US-based Alexion Pharmaceuticals. The COVID-19 …

AI software assists in radiographic fracture detection

May 18, 2021 Manufacturing and Production

GLEAMER’s BoneView, an artificial intelligence system, when combined with health professionals’ interpretations, lowered the false negative rate (undetected fractures) on …

Sandoz announces €150 million investment in antibiotic production

May 18, 2021 Manufacturing and Production EU, manufacturing, production

Sandoz, a division of Novartis, has announced plans to develop its European antibiotics manufacturing network by expanding the production capabilities …
pexels-lucy-6816451_cropped

Asthma drug Dupixent sees positive results in child trials

May 18, 2021 Manufacturing and Production FDA, asthma

Data presented at the 2021 American Thoracic Society International Conference from a Phase III trial of Dupixent (dupilumab) in children …

Pfizer-BioNTech vaccine can be kept in fridge longer than previously thought

May 18, 2021 Manufacturing and Production

The EMA has extended the recommended approved storage period for an unopened thawed vial of the Pfizer-BioNTech vaccine from five …

Major UK study finds 96% people develop antibodies after one COVID-19 jab

May 18, 2021 Manufacturing and Production

More than 96% of people develop antibodies after just one COVID-19 jab of either AstraZeneca or Pfizer, and almost 100% …

Bayer’s cardiovascular drug shows impressive Phase III results

May 11, 2021 Manufacturing and Production Bayer, chronic kidney disease, pharma, pharma news, type 2 diabetes

Bayer’s finerenone drug has been shown to significantly reduce cardiovascular death or other cardiovascular events in patients with chronic kidney …
NHS building

Abbvie psoriatic arthritis drug approved for use in Scotland

May 11, 2021 Manufacturing and Production AbbVie, NHS, arthritis, psoriatic arthritis

Abbvie’s RINVOQ (upadacitinib) drug, for the treatment of active psoriatic arthritis (PsA) in adults, has been approved for use in …
pfizer

FDA authorizes use of Pfizer vaccine for children aged 12-15

May 11, 2021 Manufacturing and Production COVID-19, FDA, Pfizer, Vaccine

The FDA announced it has expanded the emergency use of the Pfizer-BioNTech vaccine in children aged 12-15 yesterday.It was determined …

Facio Therapies announces AI collaboration for FSHD drug design

May 11, 2021 Manufacturing and Production AI, drug discovery

Facio Therapies and Iktos have announced a collaboration to apply Iktos’s generative modelling artificial intelligence (AI) technology in one of …
biogen_austria_238

Biogen and Capsigen to collaborate on novel gene therapies

May 11, 2021 Manufacturing and Production gene therapy

Biogen and Capsigen have announced a research collaboration to engineer novel adeno-associated virus (AAV) capsids that have the potential to …

AstraZeneca drug approved by FDA for kidney disease treatment

May 4, 2021 Manufacturing and Production AstraZeneca, FDA, kidney disease, pharma, pharma news

AstraZeneca’s Farxiga drug has been approved for the treatment of chronic kidney disease (CKD) in the US by the FDA.

NICE finds more SMA patients eligible for £75,000 a vial drug

May 4, 2021 Manufacturing and Production, Sales and Marketing NICE, sma

NICE has announced that more people with the rare genetic disorder spinal muscular atrophy (SMA) are to benefit from nusinersen, …

Novartis eye treatment for diabetics shows positive results in Phase III trial

May 4, 2021 Manufacturing and Production DME, Novartis, diabetic macular edema, macular edema, pharma, pharma news

Novartis’ Beovu treatment for diabetic macular edema (DME) – an eye condition that can cause blindness – has shown positive …

Needle-free pandemic influenza vaccine sees preclinical proof-of-concept

May 4, 2021 Manufacturing and Production, Sales and Marketing Vaccine technology

Enesi Pharma, a US biotechnology company developing novel vaccination products, announced the development of a solid-dose recombinant H7N9 pandemic influenza …
The Gateway to Local Adoption Series

Latest content